The past several months have witnessed the emergence of SARS-CoV-2 variants with novel
spike protein mutations that are influencing the epidemiological and clinical aspects of the …

Newly arising variants of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
are now a threat to global public health and are creating COVID‐19 surges in different …

COVID-19 is identified as a zoonotic disease caused by SARS-CoV-2, which also can cross-
transmit to many animals but not mice. Genetic modifications of SARS-CoV-2 or mice enable …

The global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
requires effective therapies against coronavirus disease 2019 (COVID-19), and neutralizing …

In addition to the rapid, global spread of SARS-CoV-2, new and comparatively more
contagious variants are of considerable concern. These emerging mutations have become a …

The global pandemic of the coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), places a heavy burden on global public …

The seasonal nature of outbreaks of respiratory viral infections with increased transmission
during low temperatures has been well established. Accordingly, temperature has been …

The outbreak of COVID-19 has proven to be an unprecedented disaster for the whole world.
The virus has inflicted billion of lives across the globe in all aspects—physically …

The sensitivity of SARS-CoV-2 variants of concern (VOCs) to neutralizing antibodies has
largely been studied in the context of key receptor binding domain (RBD) mutations …

Tracking the evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) through genomic surveillance programs is undoubtedly one of the key priorities in the …